Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL8981408 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL8533815 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL14353557 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL15348475 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL9466202 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL6453722 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL2479008 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL9305273 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL21490912 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL14353113 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023127507-A1 | POWDERED PIGMENT COMPOSITION, METHOD FOR PRODUCING POWDERED PIGMENT COMPOSITION, RESIN COMPOSITION, AND MOLDED BODY | DIC株式会社 | 2023-07-06 | — | — | WO | disclosed |
| CN-110724189-B | (1-5) -Gal- (1-6) -Man glycoprotein and preparation method and application thereof | 济南山目生物医药科技有限公司 | 2022-01-25 | — | — | CN | disclosed |
| EP-3059288-B1 | RESIN COMPOSITION AND MOLDED ARTICLE | DAINIPPON INK & CHEMICALS (JP) | 2021-12-22 | — | — | EP | disclosed |
| US-11174258-B2 | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes | IDEMITSU KOSAN CO., LTD. (JP) | 2021-11-16 | — | — | US | disclosed |
| US-20210030895-A1 | RESIN COMPOSITION AND MOLDED ARTICLE | DIC CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| US-20210024821-A1 | RESIN COMPOSITION AND MOLDED ARTICLE | DIC CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | JNC CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3034580-B1 | RESIN COMPOSITION AND MOLDED ARTICLE | DAINIPPON INK & CHEMICALS (JP) | 2020-04-29 | — | — | EP | disclosed |
| CN-110724189-A | (1-5) -Gal- (1-6) -Man glycoprotein and preparation method and application thereof | 济南山目生物医药科技有限公司 | 2020-01-24 | — | — | CN | disclosed |
| US-5213709-A | Contains thiadiazole ring | CANON KABUSHIKI KAISHA (JP) | 1993-05-25 | — | — | US | disclosed |
| CN-1017892-B | PURE ENANTIOMERS OF 4,5-DISUBSTITUTED R-BUTYROLACTAMS, PROCESS FOR THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1992-08-19 | — | — | CN | disclosed |
| EP-0455219-A1 | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1991-11-06 | — | — | EP | disclosed |
| EP-0416946-A2 | Optically active naphthalene derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-03-13 | — | — | EP | disclosed |
| US-4990508-A | Reduced side effects | TOYAMA CHEMICAL CO., LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| EP-0395390-A1 | Optically active biphenyl derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0383281-A1 | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-08-22 | — | — | EP | disclosed |
| US-4847287-A | Pure enantiomers of 4,5-disubstituted gamma-butyrolactams, and their use as antiamnestic agents | BAYER AG (DE) | 1989-07-11 | — | — | US | disclosed |
| CN-87103770-A | 4,5 two replace the pure enantiomorph of butyrolactam, their preparation method and application | — | 1988-02-03 | — | — | CN | disclosed |
| US-4380644-A | HYPOTENSIVE AGENTS | TANABE SIYAKU CO., LTD. (JP) | 1983-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11174258-B2 | Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes | KCNH2, KCNH3, KCNJ2 | ALDH1A1 397/4885LMNA 979/4885HSD17B10 4182/4885 |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | ALDH1A1 4001/4885LMNA 1958/4885HSD17B10 873/4885 |
| US-20210030895-A1 | RESIN COMPOSITION AND MOLDED ARTICLE | IK, CBR3, RER1 | ALDH1A1 643/4885LMNA 1854/4885HSD17B10 941/4885 |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | ACP1, MFAP1, PHOSPHO1 | ALDH1A1 4483/4885LMNA 1191/4885HSD17B10 1364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.